期刊文献+

卡托普利治疗心力衰竭55例临床观察 被引量:4

卡托普利治疗心力衰竭55例临床观察
下载PDF
导出
摘要 目的:观察卡托普利治疗心力衰竭的临床疗效。方法:55例确诊为心力衰竭的患者,在常规利尿剂、洋地黄及硝酸盐制剂治疗的基础上加用卡托普利。起始量为6.25mg(2次/天),直到最大耐受剂量或推荐靶剂量50mg(3次/天),定期门诊随访,坚持服药3个月。治疗前及治疗3个月后复查超声心动围观察左室舒张末内径(LVDD)和左室射血分数(LVEF),观察临床疗效。结果:卡托普利治疗3个月后,心力衰竭患者心功能明显改善,总有效率为90.5%,超声心动图显示左室舒张末期内径缩小,左室射血分数升高。结论:长期应用卡托普利治疗心力衰竭可改善心功能及心肌重构,提高生活质量,改善预后。 objective: to observe the clinical effect of the treatment with Captopril for congestive heart failure, methods:55 patients with congestive heart failure were treated with Captopril at the beginning dose of and was titrated to 150mg/day tolerated or the dose can be just rolerated, at the same time all the patients were given conventional medications( digoxin, diuretics)and the curative effect was observed. Left ventr/cular ejection fraction (LVEF) and left ventricular diastolic dimension(LVDD) were measured with echocardiography. Result: After treated for 3 months,the total effective rate in the treatment group was 90.5%. the cardiac function improved markedly such as LVDD [ (58.2 ± 13.0)vs (64.7± 8.6)mm,p 〈 0.05], LVEF [ (36.17 ±3.57% )vs(32.87 ±3.83)%, p 〈 0. 05 ]. conclusion : Captopril possesses good effects and safety in patients of Congestive Heart Failure. It can obviously improve cardiac function and prognosis.
作者 邹成红
出处 《中外妇儿健康(学术版)》 2011年第7期5-5,共1页
关键词 卡托普利 心力衰竭 临床疗效 Captopril Heart Failure Effect
  • 相关文献

参考文献6

二级参考文献17

  • 1祝之明,祝善俊.血管紧张素转换酶抑制剂对血管紧张素Ⅱ介导的钙信号传导的作用及其机理研究[J].中华心血管病杂志,1996,24(5):380-383. 被引量:9
  • 2[1]Ruiz GM, Som oza B, Bravo R, et al. Chronic losartan treatment decrease angiotensin Ⅱ - mediated facilitation of noradrenaline release in caudal artery of spontaneously hypertensive rats. Life Sci, 2000, 67: 3153 ~ 3162.
  • 3[2]Thurmann PA, Kenadi P, Schmidt A, et al. Influence of the angiotensin Ⅱantagonist valsartan on left ventricular hypertrophy in patients with esse ntial hypertension. Circulation, 1998,98 (19): 2037.
  • 4[3]Ambrose J,Pribnow DG, Girand GD, et al. Angiotensin type lreceptor antagonism with irbesartan inhibits ventriular hypertrophy and improves diastolic function in remodeling postmyocardial in farction ventricle. J AM Soc Nephrol, 1999, 10(1): 129~ 136.
  • 5O′Leary CJ;Jones PW.The left ventricular dysfunction questionnaire (LVD-36):reliability,validity,and responsiveness[J],2000(83).
  • 6Saif S;Yongfei W;Harlan M.Sex-based differences in the effect of digoxin for the treatment of heart failure[J],2002(18).
  • 7MERIT-HF Study Group.查看详情,1999.
  • 8CIBIS-II Investigator;Committees.The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomized trial,1999.
  • 9Packer M;Bristow MR;Cohn JN.The effect of Carvedilol on mortality in patients with chronic heart failure[J],1996.
  • 10Packer M;Coats AJ;Fowler MB.Effect of carvedilol on survival in severe chronic heart failure[J],2001.

共引文献2479

同被引文献31

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部